Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
Mintz PD, Neff A, MacKenzie M, Goodnough LT, Hillyer C, Kessler C, McCrae K, Menitove JE, Skikne BS, Damon L, Lopez-Plaza I, Rouault C, Crookston KP, Benjamin RJ, George J, Lin JS, Corash L, Conlan MG. Mintz PD, et al. Among authors: neff a. Transfusion. 2006 Oct;46(10):1693-704. doi: 10.1111/j.1537-2995.2006.00959.x. Transfusion. 2006. PMID: 17002625 Clinical Trial.
Feasibility of the Von Willebrand disease PREVENT trial.
Ragni MV, Machin N, James AH, Seaman CD, Malec LM, Kessler CM, Konkle BA, Kouides PA, Neff AT, Philipp CS, Brooks MM. Ragni MV, et al. Among authors: neff at. Thromb Res. 2017 Aug;156:8-13. doi: 10.1016/j.thromres.2017.05.022. Epub 2017 May 25. Thromb Res. 2017. PMID: 28577390
Internal consistency and item-total correlation of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adult people with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.
Wang M, Batt K, Kessler C, Neff A, Iyer NN, Cooper DL, Kempton CL. Wang M, et al. Among authors: neff a. Patient Prefer Adherence. 2017 Oct 25;11:1831-1839. doi: 10.2147/PPA.S141391. eCollection 2017. Patient Prefer Adherence. 2017. PMID: 29123383 Free PMC article.
Von Willebrand factor for menorrhagia: a survey and literature review.
Ragni MV, Machin N, Malec LM, James AH, Kessler CM, Konkle BA, Kouides PA, Neff AT, Philipp CS, Brambilla DJ. Ragni MV, et al. Among authors: neff at. Haemophilia. 2016 May;22(3):397-402. doi: 10.1111/hae.12898. Epub 2016 Feb 4. Haemophilia. 2016. PMID: 26843404 Free PMC article. Review.
Pilot randomized, non-inferiority, cross-over trial of once-weekly vs. three times-weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A.
Ragni MV, Yabes JG, Fogarty PF, Josephson NC, Kessler CM, Neff AT, Raffini L, Brummel-Ziedins K, Moore CG. Ragni MV, et al. Among authors: neff at. Haemophilia. 2017 Jan;23(1):e43-e46. doi: 10.1111/hae.13131. Epub 2016 Dec 11. Haemophilia. 2017. PMID: 27943502 Free PMC article. Clinical Trial. No abstract available.
Laboratory variability in the diagnosis of type 2 VWD variants.
DiGiandomenico S, Christopherson PA, Haberichter SL, Abshire TC, Montgomery RR, Flood VH; Zimmerman Program Investigators. DiGiandomenico S, et al. J Thromb Haemost. 2021 Jan;19(1):131-138. doi: 10.1111/jth.15129. Epub 2020 Nov 10. J Thromb Haemost. 2021. PMID: 33049112 Free PMC article.
323 results